Trulicity was approved by the U.S. Food and Drug Administration (FDA) on March 24, 2017 [1].
What is Trulicity used for?
Trulicity is a prescription medication used to improve blood sugar control in adults with type 2 diabetes mellitus [2]. It is also used to reduce the risk of major adverse cardiovascular events (such as heart attack, stroke, or death) in adults with type 2 diabetes mellitus and established cardiovascular disease, or with multiple cardiovascular risk factors [2].
How does Trulicity work?
Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist [3]. It works by mimicking the action of the GLP-1 hormone, which helps to:
* Increase insulin secretion from the pancreas when blood sugar levels are high [3].
* Decrease the amount of sugar released by the liver [3].
* Slow down the rate at which food leaves the stomach, which can help to reduce blood sugar spikes after meals [3].
Who makes Trulicity?
Trulicity is manufactured by Eli Lilly and Company [4].
When does Trulicity patent expire?
Patent expiry dates for medications can be complex due to various patents covering different aspects of a drug, including formulation, method of use, and manufacturing [5]. Information regarding specific patent expiry dates for Trulicity and potential generic or biosimilar entry can be found on resources like DrugPatentWatch.com [5].